These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 25012937

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives.
    Eikel D, Lampen A, Nau H.
    Chem Res Toxicol; 2006 Feb; 19(2):272-8. PubMed ID: 16485903
    [Abstract] [Full Text] [Related]

  • 3. Epigenetic evidence of an Ac/Dc axis by VPA and SAHA.
    Lunke S, Maxwell S, Khurana I, K N H, Okabe J, Al-Hasani K, El-Osta A.
    Clin Epigenetics; 2021 Mar 20; 13(1):58. PubMed ID: 33743782
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
    Liu S, Klisovic RB, Vukosavljevic T, Yu J, Paschka P, Huynh L, Pang J, Neviani P, Liu Z, Blum W, Chan KK, Perrotti D, Marcucci G.
    J Pharmacol Exp Ther; 2007 Jun 20; 321(3):953-60. PubMed ID: 17389244
    [Abstract] [Full Text] [Related]

  • 7. Epigenetic landscape of amphetamine and methamphetamine addiction in rodents.
    Godino A, Jayanthi S, Cadet JL.
    Epigenetics; 2015 Jun 20; 10(7):574-80. PubMed ID: 26023847
    [Abstract] [Full Text] [Related]

  • 8. Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity.
    Fu Y, Zhang P, Ge J, Cheng J, Dong W, Yuan H, Du Y, Yang M, Sun R, Jiang H.
    Int J Biochem Cell Biol; 2014 Sep 20; 54():68-77. PubMed ID: 25019367
    [Abstract] [Full Text] [Related]

  • 9. Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes.
    Milutinovic S, D'Alessio AC, Detich N, Szyf M.
    Carcinogenesis; 2007 Mar 20; 28(3):560-71. PubMed ID: 17012225
    [Abstract] [Full Text] [Related]

  • 10. New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells.
    Novohradsky V, Zerzankova L, Stepankova J, Vrana O, Raveendran R, Gibson D, Kasparkova J, Brabec V.
    Biochem Pharmacol; 2015 Jun 01; 95(3):133-44. PubMed ID: 25888926
    [Abstract] [Full Text] [Related]

  • 11. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC, Jacob LA, Aparna S, Lokanatha D, Saldanha SC.
    J Cancer Res Ther; 2014 Jun 01; 10(3):469-78. PubMed ID: 25313724
    [Abstract] [Full Text] [Related]

  • 12. Energy-optimised pharmacophore approach to identify potential hotspots during inhibition of Class II HDAC isoforms.
    Ganai SA, Shanmugam K, Mahadevan V.
    J Biomol Struct Dyn; 2015 Jun 01; 33(2):374-87. PubMed ID: 24460542
    [Abstract] [Full Text] [Related]

  • 13. Exploration of the valproic acid binding site on histone deacetylase 8 using docking and molecular dynamic simulations.
    Bermúdez-Lugo JA, Perez-Gonzalez O, Rosales-Hernández MC, Ilizaliturri-Flores I, Trujillo-Ferrara J, Correa-Basurto J.
    J Mol Model; 2012 Jun 01; 18(6):2301-10. PubMed ID: 21968575
    [Abstract] [Full Text] [Related]

  • 14. Exploring the inhibitory activity of valproic acid against the HDAC family using an MMGBSA approach.
    Sixto-López Y, Bello M, Correa-Basurto J.
    J Comput Aided Mol Des; 2020 Aug 01; 34(8):857-878. PubMed ID: 32180123
    [Abstract] [Full Text] [Related]

  • 15. Targeting of histone deacetylases to reactivate tumour suppressor genes and its therapeutic potential in a human cervical cancer xenograft model.
    Feng D, Wu J, Tian Y, Zhou H, Zhou Y, Hu W, Zhao W, Wei H, Ling B, Ma C.
    PLoS One; 2013 Aug 01; 8(11):e80657. PubMed ID: 24260446
    [Abstract] [Full Text] [Related]

  • 16. Identification of an epigenetic signature of early mouse liver regeneration that is disrupted by Zn-HDAC inhibition.
    Huang J, Schriefer AE, Yang W, Cliften PF, Rudnick DA.
    Epigenetics; 2014 Nov 01; 9(11):1521-31. PubMed ID: 25482284
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.